Experienced in Generalized Tonic-Clonic Seizure

David C. Reutens

St. Lucia Campus, Building 57, Research Road, 
Brisbane, QLD, AU 
Experienced in Generalized Tonic-Clonic Seizure
St. Lucia Campus, Building 57, Research Road, 
Brisbane, QLD, AU 
OverviewLocationsClinical Research

Overview

David Reutens practices in Brisbane, Australia. Mr. Reutens is rated as an Experienced expert by MediFind in the treatment of Generalized Tonic-Clonic Seizure. His top areas of expertise are Epilepsy, Seizures, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), and Generalized Tonic-Clonic Seizure.

His clinical research consists of co-authoring 153 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Generalized Tonic-Clonic Seizure.

Gender
Male

Locations

St. Lucia Campus, Building 57, Research Road, Brisbane, QLD 4072, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 Via an Implantable Pump and a Cranial Port and Double Lumen Catheter (ICVRX) in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 Via an Implantable Pump and a Cranial Port and Double Lumen Catheter (ICVRX) in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Combination product
Study Drug: ICV delivery of CT-010 via an implantable pump and a cranial port and dual lumen catheter (CIC)
Study Phase: Phase 2

153 Total Publications

Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs.
Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reutens's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile